1 November 2021 in Biosensors and Bioelectronics
Although urinary exosomal microRNAs (miRNAs) have recently emerged as potential biomarkers, clinical applications are still limited due to their low concentration in small volumes of clinical samples. Therefore, the development of a non-invasive, specific diagnostic tool, along with profiling exosomal miRNA markers from urine, remains a significant challenge. Here, we present hydrogel-based hybridization chain reaction (HCR) for multiplex signal amplification to detect urinary exosomal miRNAs from human clinical samples. We succeeded in identifying small amounts (~amol) of exosomal miRNAs from 600 μL of urine with up to ~35-fold amplification and enhanced detection limits by over an order of magnitude for two miRNA biomarker candidates, hsa-miR-6090 and hsa-miR-3665. Furthermore, we proposed ratiometric analysis without requiring normalization to a reference miRNA and validated the clinical diagnostic potential toward differentiating prostate cancer patients from healthy controls. Our hydrogel-based HCR could serve as a new diagnostic platform for a non-invasive liquid biopsy before burdensome tissue biopsy of various diseases, including prostate cancer screening, complementing the PSA test.
13 April 2023 in Biosensors and Bioelectronics
Digital enzyme linked immunosorbent assays (ELISA) can be used to detect various antigens such as spike (S) or nucleocapsid (N) proteins of SARS-CoV-2, with much higher sensitivity compared to that achievable using conventional antigen tests. However, the use of microbeads and oil for compartmentalization in these assays limits their user-friendliness and causes loss of assay information due to the loss of beads during the process. To improve the sensitivity of antigen test, here, we developed an oil- and bead-free single molecule counting assay, with rolling circle amplification (RCA) on a substrate. With RCA, the signal is localized at the captured region of an antigen, and the signal from a single antigen molecule can be visualized using the same immune-reaction procedures as in the conventional ELISA. Substrate-based single molecule assay was theoretically evaluated for kd value, and the concentration of capture and detection antibodies. As a feasibility test, biotin-conjugated primer and mouse IgG conjugates were detected even at femto-molar concentrations with this digital immuno-RCA. Using this method, we detected the N protein of SARS-CoV-2 with a limit of detection less than 1 pg/mL more than 100-fold improvement compared to the detection using conventional ELISA. Furthermore, testing of saliva samples from COVID-19 patients and healthy controls (n = 50) indicated the applicability of the proposed method for detection of SARS-CoV-2 with 99.5% specificity and 90.9% sensitivity.
4 August 2020 in Lab on a Chip
A microfluidic aqueous two-phase system to isolate extracellular vesicles from small volumes of sample with high recovery efficiency.
10 October 2025 in Biosensors and Bioelectronics
Early detection of ultra-low-abundance protein biomarkers is critical for improving clinical outcomes. However, many conventional immunoassays and proteomic platforms exhibit high limits of detection (LOD) and long incubation times, complicating low-to sub-femtomolar measurements. In addition, state-of-the-art digital ELISAs often rely on magnetic beads, oil emulsions, and pump-valve benchtop analyzers-bulky and costly systems that hinder broad deployment. Here, we present a digital ELISA (dELISA) that lowers LOD and shortens time-to-result by harnessing rapid, repeated femtoliter-scale droplet evaporation on a bead-free, oil-free micro-droplet array. Cyclic ≈30-fL droplet generation/evaporation at the air-water interface enriches analytes at antibody-functionalized surfaces, while evaporation-induced convection and a shortened diffusion path increase antigen-antibody encounter frequency. For cardiac troponin I, the platform achieved an LOD of 64.23 fM with 300 evaporation cycles, a >280-fold improvement over 96-well ELISA. The same capture obtained after 120 min of static soaking occurred in 1.76 min with cyclic evaporation. Counts matched a Poisson capture model, with binding increasing linearly with cycle number. In diluted human plasma, the assay maintained >86 % recovery with minimal non-specific adsorption. Simple fabrication, the absence of beads, oils, and complex fluidic hardware, and high-throughput compatibility indicate strong potential for point-of-care use and integration into diverse digital immunoassay applications.